In this study, we present and compare the tertiary structures of the subdomains in SMYD3 to the SET domains in other proteins to inform the development of specific small molecule inhibitors that could be useful in the understanding and treatment of SMYD3-positive cancers. The gene discussed is SMYD3; the disease is cancer.